Spots Global Cancer Trial Database for A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
Official Title: A Phase 1b/2 Study Evaluating the Safety, Tolerability, Efficacy, and Pharmacokinetics of Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer (FORTITUDE-103).
Study ID: NCT05322577
Study Description
Brief Summary: The main objectives of this study are to evaluate the safety and tolerability of bemarituzumab in combination with other anti-cancer therapies, and to evaluate the efficacy of bemarituzumab in combination with S-1 and oxaliplatin (SOX) and nivolumab as assessed by objective response.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Northport Veterans Affairs Medical Center, Northport, New York, United States
Ogaki Municipal Hospital, Ogaki-shi, Gifu, Japan
Gunma University Hospital, Maebashi-shi, Gunma, Japan
St Marianna University Hospital, Kawasaki-shi, Kanagawa, Japan
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center, Yokohama-shi, Kanagawa, Japan
Kochi Health Sciences Center, Kochi-shi, Kochi, Japan
Tohoku University Hospital, Sendai-shi, Miyagi, Japan
Okayama University Hospital, Okayama-shi, Okayama, Japan
Osaka General Medical Center, Osaka-shi, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital, Takatsuki-shi, Osaka, Japan
Shizuoka General Hospital, Shizuoka-shi, Shizuoka, Japan
Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan
Dokkyo Medical University Hospital, Shimotsuga-gun, Tochigi, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Severance Hospital Yonsei University Health System, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
National University Hospital, Singapore, , Singapore
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
